Figure 4

Comparative cumulative achievement of the age-dependent lower limit of normal (LLN) for total lymphocytes after the end of chemotherapy in patients aged ≤ 11 years (grey) and patients aged 12–18 years (black) with ALL (A), HD (B), ES (C), overall including all three disease entities (D), in patients aged ≤ 11 years with ALL in comparison with HD and ES (E), and in patients aged 12–18 years with ALL in comparison with HD and ES (F).